- Home
- FTK vs LAB Comparison
FTK vs LAB Comparison
Compare FTK & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTK
- LAB
- Stock Information
- Founded
- FTK 1985
- LAB 1999
- Country
- FTK United States
- LAB United States
- Employees
- FTK N/A
- LAB N/A
- Industry
- FTK Major Chemicals
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- FTK Industrials
- LAB Industrials
- Exchange
- FTK Nasdaq
- LAB Nasdaq
- Market Cap
- FTK 440.6M
- LAB 372.1M
- IPO Year
- FTK N/A
- LAB 2011
- Fundamental
- Price
- FTK $14.39
- LAB $1.39
- Analyst Decision
- FTK Buy
- LAB Buy
- Analyst Count
- FTK 2
- LAB 2
- Target Price
- FTK $12.00
- LAB $2.50
- AVG Volume (30 Days)
- FTK 774.3K
- LAB 2.6M
- Earning Date
- FTK 08-05-2025
- LAB 07-30-2025
- Dividend Yield
- FTK N/A
- LAB N/A
- EPS Growth
- FTK 683.07
- LAB N/A
- EPS
- FTK 0.46
- LAB N/A
- Revenue
- FTK $202,013,000.00
- LAB $169,687,000.00
- Revenue This Year
- FTK $16.63
- LAB N/A
- Revenue Next Year
- FTK $9.94
- LAB $12.18
- P/E Ratio
- FTK $31.36
- LAB N/A
- Revenue Growth
- FTK 11.96
- LAB 33.86
- 52 Week Low
- FTK $3.79
- LAB $0.92
- 52 Week High
- FTK $16.87
- LAB $2.41
- Technical
- Relative Strength Index (RSI)
- FTK 50.75
- LAB 60.31
- Support Level
- FTK $14.00
- LAB $1.27
- Resistance Level
- FTK $14.84
- LAB $1.31
- Average True Range (ATR)
- FTK 0.72
- LAB 0.11
- MACD
- FTK -0.16
- LAB 0.01
- Stochastic Oscillator
- FTK 55.81
- LAB 50.89
About FTK Flotek Industries Inc.
Flotek Industries Inc is a technology-driven specialty chemistry and data company. It has two reportable segments: Its Chemistry Technologies segment includes specialty chemistries, logistics and technology services. It also include integrated oil and gas companies, oilfield services companies, independent oil and gas companies, national and state-owned oil companies, and international supply chain management companies. The Data Analytics segment provides analytical measurement solutions and deliver real-time information and insights to customers to enable optimization of operations and reduction of emissions and their carbon intensity. Key revenue comes from its Chemistry Technologies segment.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.